MedPath

Comparison of two insulin treatments in diabetic ketoacidosis

Not Applicable
Conditions
Diabetes.
Insulin-dependent diabetes mellitus
Registration Number
IRCT201610297654N3
Lead Sponsor
Hamedan University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

inclusion criteria: blood sugar>300mg/d ; PH < 3.7; urine keton +2 or more with dipstick or in urine analysis ; history of polydipsia, Frequency, Enuresis, weight loss
exclusion criteria: DKA caused by infections in patients;patients with epilepsy or underline disease;patients with endocrine disorders;patients with inborn error of metabolism patients with metabolic acidosis that treated with intravenous bicarbonate in an other center; patients that PH and dehydration's become worse

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ABG. Timepoint: Every 4 hours. Method of measurement: Peripheral blood samples.;The number of hospitalization. Timepoint: end of study. Method of measurement: The number.;ICU admission. Timepoint: end of study. Method of measurement: The number.;Sign of brain edema. Timepoint: daily. Method of measurement: Clinical.;Electrolysis imbalance. Timepoint: Every 4 hours. Method of measurement: Peripheral blood samples.;Response time to treatment. Timepoint: Every 2 hours. Method of measurement: blood sugar with glucometer and ABG.;Hpoglycemia. Timepoint: Every 2 hours. Method of measurement: blood sugar with glucometer.
Secondary Outcome Measures
NameTimeMethod
Hypoglycemia. Timepoint: every 2 hours. Method of measurement: blood sugar with glucometer.;Electrolysis imbalance. Timepoint: every 4 hours. Method of measurement: Peripheral blood samples.;Sign of brain edema. Timepoint: every 2 hours. Method of measurement: clinical.
© Copyright 2025. All Rights Reserved by MedPath